Granulocytic Sarcoma

• CLINICAL_TRIALS trial_result · 2024-09-19
  Clinical Trial Update: CPI-613, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Granulocytic Sarcoma [Phase 1]

  Phase 1 trial evaluating the combination of CPI-613 (devimistat) with cytarabine and mitoxantrone hydrochloride in relapsed or refractory ac…

• CLINICAL_TRIALS withdrawal · 2024-09-19
  Clinical Trial Update: CPI-613 Given With Metformin in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) [Phase 2]

  A Phase 2 clinical trial evaluating CPI-613 (devimistat) in combination with metformin for relapsed or refractory acute myeloid leukemia has…